Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Adjuvant trastuzumab increases survival in early-stage breast cancer

Sep. 19, 2005

huN901-DM1 enters clinical testing for multiple myeloma

Sep. 9, 2005

Avax files IND for phase I/II NSCLC study of AC Vaccine Therapeutic

Sep. 9, 2005

Phase I data on the effects of SB-485232 in renal cell carcinoma and multiple myeloma

Sep. 6, 2005

Galiximab demonstrates favorable safety profile in follicular lymphoma patients

Sep. 5, 2005

sBLA filed for Erbitux for head and neck cancer

Aug. 31, 2005

New study evaluates Cotara for glioblastoma multiforme

Aug. 31, 2005

Advaxis completes preclinical toxicology studies for Lovaxin C

Aug. 31, 2005

New phase II study assesses WF-10 as adjuvant treatment for pancreatic cancer

Aug. 30, 2005

Anti-CD69 MAb: A novel approach to cancer immunotherapy

Aug. 30, 2005

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...